Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Finasteride effectively blocks enzyme causing male pattern baldness.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Gene differences may affect baldness treatment response in Korean men.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Ocimum basilicum L. and red Oryza sativa L. may help with hair loss and prostate issues.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Some herbs show promise as antiandrogenic agents.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The study created a new method to test drugs that affect hormone processing in skin.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride potentially treats hair loss by reducing DHT production.